Cargando…
Structural characterization of a protein adsorbed on aluminum hydroxide adjuvant in vaccine formulation
The heterogeneous composition of vaccine formulations and the relatively low concentration make the characterization of the protein antigens extremely challenging. Aluminum-containing adjuvants have been used to enhance the immune response of several antigens over the last 90 years and still remain...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538755/ https://www.ncbi.nlm.nih.gov/pubmed/31149351 http://dx.doi.org/10.1038/s41541-019-0115-7 |
_version_ | 1783422231907401728 |
---|---|
author | Cerofolini, Linda Giuntini, Stefano Ravera, Enrico Luchinat, Claudio Berti, Francesco Fragai, Marco |
author_facet | Cerofolini, Linda Giuntini, Stefano Ravera, Enrico Luchinat, Claudio Berti, Francesco Fragai, Marco |
author_sort | Cerofolini, Linda |
collection | PubMed |
description | The heterogeneous composition of vaccine formulations and the relatively low concentration make the characterization of the protein antigens extremely challenging. Aluminum-containing adjuvants have been used to enhance the immune response of several antigens over the last 90 years and still remain the most commonly used. Here, we show that solid-state NMR and isotope labeling methods can be used to characterize the structural features of the protein antigen component of vaccines and to investigate the preservation of the folding state of proteins adsorbed on Alum hydroxide matrix, providing the way to identify the regions of the protein that are mainly affected by the presence of the inorganic matrix. l-Asparaginase from E. coli has been used as a pilot model of protein antigen. This methodology can find application in several steps of the vaccine development pipeline, from the antigen optimization, through the design of vaccine formulation, up to stability studies and manufacturing process. |
format | Online Article Text |
id | pubmed-6538755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-65387552019-05-30 Structural characterization of a protein adsorbed on aluminum hydroxide adjuvant in vaccine formulation Cerofolini, Linda Giuntini, Stefano Ravera, Enrico Luchinat, Claudio Berti, Francesco Fragai, Marco NPJ Vaccines Article The heterogeneous composition of vaccine formulations and the relatively low concentration make the characterization of the protein antigens extremely challenging. Aluminum-containing adjuvants have been used to enhance the immune response of several antigens over the last 90 years and still remain the most commonly used. Here, we show that solid-state NMR and isotope labeling methods can be used to characterize the structural features of the protein antigen component of vaccines and to investigate the preservation of the folding state of proteins adsorbed on Alum hydroxide matrix, providing the way to identify the regions of the protein that are mainly affected by the presence of the inorganic matrix. l-Asparaginase from E. coli has been used as a pilot model of protein antigen. This methodology can find application in several steps of the vaccine development pipeline, from the antigen optimization, through the design of vaccine formulation, up to stability studies and manufacturing process. Nature Publishing Group UK 2019-05-28 /pmc/articles/PMC6538755/ /pubmed/31149351 http://dx.doi.org/10.1038/s41541-019-0115-7 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Cerofolini, Linda Giuntini, Stefano Ravera, Enrico Luchinat, Claudio Berti, Francesco Fragai, Marco Structural characterization of a protein adsorbed on aluminum hydroxide adjuvant in vaccine formulation |
title | Structural characterization of a protein adsorbed on aluminum hydroxide adjuvant in vaccine formulation |
title_full | Structural characterization of a protein adsorbed on aluminum hydroxide adjuvant in vaccine formulation |
title_fullStr | Structural characterization of a protein adsorbed on aluminum hydroxide adjuvant in vaccine formulation |
title_full_unstemmed | Structural characterization of a protein adsorbed on aluminum hydroxide adjuvant in vaccine formulation |
title_short | Structural characterization of a protein adsorbed on aluminum hydroxide adjuvant in vaccine formulation |
title_sort | structural characterization of a protein adsorbed on aluminum hydroxide adjuvant in vaccine formulation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538755/ https://www.ncbi.nlm.nih.gov/pubmed/31149351 http://dx.doi.org/10.1038/s41541-019-0115-7 |
work_keys_str_mv | AT cerofolinilinda structuralcharacterizationofaproteinadsorbedonaluminumhydroxideadjuvantinvaccineformulation AT giuntinistefano structuralcharacterizationofaproteinadsorbedonaluminumhydroxideadjuvantinvaccineformulation AT raveraenrico structuralcharacterizationofaproteinadsorbedonaluminumhydroxideadjuvantinvaccineformulation AT luchinatclaudio structuralcharacterizationofaproteinadsorbedonaluminumhydroxideadjuvantinvaccineformulation AT bertifrancesco structuralcharacterizationofaproteinadsorbedonaluminumhydroxideadjuvantinvaccineformulation AT fragaimarco structuralcharacterizationofaproteinadsorbedonaluminumhydroxideadjuvantinvaccineformulation |